219 results on '"Stossi, Fabio"'
Search Results
2. A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals
3. Machine learning methods for endocrine disrupting potential identification based on single-cell data
4. Transcriptome, proteome, and protein synthesis within the intracellular cytomatrix
5. Oral follicle stimulating hormone (FSH) receptor agonist affects granulosa cells differently than recombinant human FSH
6. Sensitive image-based chromatin binding assays using inducible ERα to rapidly characterize estrogenic chemicals and mixtures
7. Endocrine disrupting chemicals differentially alter intranuclear dynamics and transcriptional activation of estrogen receptor-α
8. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity
9. Single-Cell Distribution Analysis of AR Levels by High-Throughput Microscopy in Cell Models: Application for Testing Endocrine-Disrupting Chemicals
10. A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals
11. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer.
12. A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals
13. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
14. Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease
15. Unique cellular protrusions mediate breast cancer cell migration by tethering to osteogenic cells
16. The Signaling Pathways Project, an integrated ‘omics knowledgebase for mammalian cellular signaling pathways
17. A homing system targets therapeutic T cells to brain cancer
18. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer
19. Abstract P6-11-15: Lipid accumulation in residual triple negative breast cancer cells surviving chemotherapy treatment
20. Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin Condensation
21. Effects of α and β-adrenergic signaling on innate immunity and Porphyromonas gingivalis virulence in an invertebrate model
22. Defining Estrogenic Mechanisms of Bisphenol A Analogs through High Throughput Microscopy-Based Contextual Assays
23. Steroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells
24. Abstract 6355: A characterisation of direct and indirect transcription factor inhibition to target brachyury in chordoma
25. Abstract LB517A: The role of EGFR in resistance to tucatinib and its therapeutic implications
26. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection
27. Retraction Note: A homing system targets therapeutic T cells to brain cancer
28. The Human Nose Organoid Respiratory Virus Model: an Ex Vivo Human Challenge Model To Study Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pathogenesis and Evaluate Therapeutics
29. Abstract P4-01-01: Resistance to next generation tyrosine kinase inhibitors (TKIs) in HER2-positive breast cancer (BC): Role of HER and PIK3CA mutations and development of new treatment strategies and study models
30. Abstract PD8-06: Acquired resistance to tucatinib is associated with EGFR amplification in HER2+ breast cancer (BC) models and can be overcome by a more complete blockade of HER receptor layer
31. Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC
32. Quality Control for Single Cell Imaging Analytics Using Endocrine Disruptor-Induced Changes in Estrogen Receptor Expression
33. Epigenetic Silencing of MYC By Proteasome Inhibitors
34. Effects of α and β-adrenergic signaling on innate immunity and Porphyromonas gingivalis virulence in an invertebrate model.
35. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation
36. Abstract 1077: Acquired neratinib resistance is associated with acquisition of HER2 and PIK3CA mutations and can be overcome using potent drug combinations in HER2-positive breast cancer models
37. #17: Disease and Immunoprophylaxis Model of Human Nose Organoids to Study SARS-CoV-2 and RSV Infection
38. Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen
39. Abstract PD3-09: HER2 L755S mutation is acquired upon resistance to lapatinib and neratinib and confers cross-resistance to tucatinib and trastuzumab in HER2-positive breast cancer cell models
40. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
41. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
42. Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses
43. Quality Control for Single Cell Imaging Analytics Using Endocrine DisruptorInduced Changes in Estrogen Receptor Expression.
44. The Estrogen-Regulated Transcription Factor PITX1 Coordinates Gene-Specific Regulation by Estrogen Receptor-Alpha in Breast Cancer Cells
45. Classification of estrogenic compounds by coupling high content analysis and machine learning algorithms
46. Abstract 1911: HER2 L755S mutation is associated with acquired resistance to lapatinib and neratinib, and confers cross-resistance to tucatinib in HER2-positive breast cancer models
47. A Genetically Engineered Rotavirus NSP2 Phosphorylation Mutant Impaired in Viroplasm Formation and Replication Shows an Early Interaction between vNSP2 and Cellular Lipid Droplets
48. Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress
49. Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity
50. The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.